Your browser doesn't support javascript.
loading
MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.
Liu, Li; Xu, Feng; Chang, Chun-Kang; He, Qi; Wu, Ling-Yun; Zhang, Zheng; Li, Xiao.
Affiliation
  • Liu L; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
  • Xu F; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
  • Chang CK; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
  • He Q; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
  • Wu LY; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
  • Zhang Z; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
  • Li X; Department of Hematology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai 200233, China.
Cell Death Dis ; 8(10): e3126, 2017 10 12.
Article in En | MEDLINE | ID: mdl-29022893

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Erythroblastic, Acute / Cyclin-Dependent Kinase Inhibitor p21 / Enhancer of Zeste Homolog 2 Protein / N-Myc Proto-Oncogene Protein Limits: Humans Language: En Journal: Cell Death Dis Year: 2017 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Erythroblastic, Acute / Cyclin-Dependent Kinase Inhibitor p21 / Enhancer of Zeste Homolog 2 Protein / N-Myc Proto-Oncogene Protein Limits: Humans Language: En Journal: Cell Death Dis Year: 2017 Document type: Article Affiliation country: China Country of publication: United kingdom